Voya Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $868K | Sell |
4,145
-434
| -9% | -$96.3K | 0.09% | 101 |
|
|
2025
Q4 | $1.06M | Sell |
4,579
-388
| -8% | -$88.4K | 0.1% | 94 |
|
|
2025
Q3 | $1.11M | Sell |
4,967
-383
| -7% | -$78K | 0.11% | 93 |
|
|
2025
Q2 | $975K | Buy |
5,350
+1,326
| +33% | +$246K | 0.1% | 103 |
|
|
2025
Q1 | $826K | Sell |
4,024
-1,065
| -21% | -$207K | 0.09% | 105 |
|
|
2024
Q4 | $897K | Buy |
5,089
+745
| +17% | +$137K | 0.1% | 103 |
|
|
2024
Q3 | $846K | Buy |
4,344
+724
| +20% | +$135K | 0.09% | 102 |
|
|
2024
Q2 | $612K | Buy |
3,620
+36
| +1% | +$5.96K | 0.07% | 135 |
|
|
2024
Q1 | $646K | Sell |
3,584
-571
| -14% | -$98.4K | 0.07% | 123 |
|
|
2023
Q4 | $643K | Buy |
4,155
+94
| +2% | +$13.7K | 0.08% | 121 |
|
|
2023
Q3 | $618K | Sell |
4,061
-137
| -3% | -$20.1K | 0.08% | 117 |
|
|
2023
Q2 | $559K | Sell |
4,198
-180
| -4% | -$26.4K | 0.07% | 130 |
|
|
2023
Q1 | $691K | Sell |
4,378
-52
| -1% | -$7.95K | 0.09% | 109 |
|
|
2022
Q4 | $720K | Buy |
4,430
+266
| +6% | +$40.8K | 0.09% | 108 |
|
|
2022
Q3 | $594K | Buy |
4,164
+48
| +1% | +$6.89K | 0.08% | 124 |
|
|
2022
Q2 | $634K | Sell |
4,116
-141
| -3% | -$21.5K | 0.08% | 117 |
|
|
2022
Q1 | $697K | Sell |
4,257
-1,556
| -27% | -$226K | 0.08% | 123 |
|
|
2021
Q4 | $790K | Buy |
5,813
+325
| +6% | +$38.4K | 0.09% | 119 |
|
|
2021
Q3 | $597K | Buy |
5,488
+249
| +5% | +$28.5K | 0.07% | 139 |
|
|
2021
Q2 | $588K | Sell |
5,239
-41,897
| -89% | -$4.72M | 0.08% | 141 |
|
|
2021
Q1 | $5.03M | Buy |
47,136
+29
| +0.1% | +$3.1K | 0.2% | 84 |
|
|
2020
Q4 | $4.96M | Buy |
47,107
+2,349
| +5% | +$226K | 0.21% | 73 |
|
|
2020
Q3 | $3.89M | Sell |
44,758
-5,836
| -12% | -$549K | 0.19% | 81 |
|
|
2020
Q2 | $4.88M | Sell |
50,594
-7,429
| -13% | -$654K | 0.26% | 64 |
|
|
2020
Q1 | $4.37M | Sell |
58,023
-4,082
| -7% | -$348K | 0.24% | 69 |
|
|
2019
Q4 | $5.5M | Buy |
62,105
+2,973
| +5% | +$247K | 0.27% | 69 |
|
|
2019
Q3 | $4.43M | Buy |
59,132
+885
| +2% | +$60.7K | 0.24% | 81 |
|
|
2019
Q2 | $4.08M | Buy |
58,247
+1,922
| +3% | +$151K | 0.22% | 86 |
|
|
2019
Q1 | $4.5M | Buy |
56,325
+6,017
| +12% | +$492K | 0.26% | 79 |
|
|
2018
Q4 | $4.58M | Buy |
50,308
+7,385
| +17% | +$649K | 0.31% | 70 |
|
|
2018
Q3 | $4.04M | Buy |
42,923
+5,245
| +14% | +$497K | 0.24% | 82 |
|
|
2018
Q2 | $3.48M | Buy |
37,678
+374
| +1% | +$36.5K | 0.23% | 87 |
|
|
2018
Q1 | $3.52M | Sell |
37,304
-2,678
| -7% | -$294K | 0.23% | 94 |
|
|
2017
Q4 | $3.91M | Sell |
39,982
-1,466
| -4% | -$138K | 0.25% | 89 |
|
|
2017
Q3 | $3.69M | Sell |
41,448
-12,984
| -24% | -$988K | 0.25% | 86 |
|
|
2017
Q2 | $3.94M | Buy |
54,432
+7,508
| +16% | +$505K | 0.28% | 73 |
|
|
2017
Q1 | $3.09M | Buy |
46,924
+1,361
| +3% | +$85.6K | 0.24% | 89 |
|
|
2016
Q4 | $2.86M | Buy |
45,563
+1,640
| +4% | +$100K | 0.25% | 81 |
|
|
2016
Q3 | $2.76M | Buy |
43,923
+3,697
| +9% | +$239K | 0.28% | 73 |
|
|
2016
Q2 | $2.49M | Buy |
40,226
+8,178
| +26% | +$498K | 0.29% | 68 |
|
|
2016
Q1 | $1.83M | Buy |
32,048
+4,965
| +18% | +$277K | 0.25% | 74 |
|
|
2015
Q4 | $1.62M | Buy |
27,083
+7,668
| +39% | +$442K | 0.24% | 76 |
|
|
2015
Q3 | $1.02M | Sell |
19,415
-3,592
| -16% | -$234K | 0.18% | 95 |
|
|
2015
Q2 | $1.55M | Buy |
23,007
+154
| +0.7% | +$10.1K | 0.27% | 70 |
|
|
2015
Q1 | $1.33M | Buy |
+22,853
| New | +$1.38M | 0.26% | 89 |
|
Other funds holding ABBV
VCM
VPM
Voya Financial Advisors's ABBV Position: Q1 2026 in Review
Voya Financial Advisors reduced its AbbVie (ABBV) stake by 9.5% in Q1 2026, selling an estimated $96.3K and leaving 4,145 shares worth $868K. The position accounts for 0.09% of the portfolio, ranked #101.
Voya Financial Advisors first reported a position in ABBV in Q1 2015 and has held it in 45 quarters since. The position peaked at $5.5M in Q4 2019. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Voya Financial Advisors held 4,145 shares of AbbVie worth $868K as of Q1 2026.
- Voya Financial Advisors sold 434 AbbVie shares in Q1 2026, an estimated $96.3K.
- AbbVie made up 0.09% of Voya Financial Advisors's portfolio in Q1 2026, its #101 holding.
- Voya Financial Advisors first reported a position in AbbVie in Q1 2015 and has held it in 45 quarters since.
- Voya Financial Advisors's AbbVie position peaked at $5.5M in Q4 2019.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Voya Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.